Guggenheim Raises Its Price Target on Arcutis Biotherapeutics, Inc. (ARQT) to $35 and Maintains a Buy Rating
Business
Archived
•
March 6, 2026
•
2 views
Source: https://finance.yahoo.com/rss/topstories - Read Original
"House Plans for Structures New and Old"
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Monetize your website or boost your business with Code-Oryx. Join the network today!"
"Commision Art Work or Just pure Beauty."